Bioextrax AB

Equities

BIOEX

SE0016276752

Environmental Services & Equipment

Market Closed - Nasdaq Stockholm Other stock markets 11:24:05 2024-04-23 am EDT			5-day change	1st Jan Change
2.25 ^SEK	+3.45%		-5.26%	-25.86%

Feb. 16	Bioextrax AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 16	Bioextrax AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Bioextrax AB has filed an IPO in the amount of SEK 6.47045 million.

March 25, 2020 at 12:00 am EDT

Bioextrax AB (publ) has filed an IPO in the amount of SEK 6.47045 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 330,125 PriceRange: SEK 19.6 Transaction Features: Sponsor Backed Offering

Latest news about Bioextrax AB

Bioextrax AB Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 16	CI
Bioextrax AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 16	CI
Bioextrax AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 17	CI
Bioextrax AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-24	CI
Bioextrax AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
Bioextrax AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-15	CI
Bioextrax AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Bioextrax Receives Intention for Patent By EPO	22-09-09	MT
Bioextrax AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-30	CI
Bioextrax AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Bioextrax AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-24	CI
Bioextrax AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-24	CI
Bioextrax AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-25	CI
Bioextrax AB Publ Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-26	CI
Bioextrax AB has completed an IPO in the amount of SEK 6.47045 million.	20-04-27	CI
Bioextrax AB has filed an IPO in the amount of SEK 6.47045 million.	20-03-25	CI
Bioextrax announced that it has received funding from Lunds Universitets Innovationssystem AB.	15-03-17	CI

Chart Bioextrax AB

Duration

Period

More charts

Company Profile

Bioextrax AB (publ) is a Sweden-based biotech research company. The Company specializes in research and development of technology platforms that are used to convert organic waste into various environmentally friendly materials. Bioextrax AB (publ) develops a potent microbial extraction technology, which is realized through applications such as Bioplastics (PHA), Organic Hydrolyzed Protein and Keratin Fibers.

Sector

Environmental Services & Equipment

Calendar

2024-05-15 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Environmental Biotechnology

	1st Jan change	Capi.
BIOEXTRAX AB	-25.86%	5.82M
AVANTIUM N.V.	-28.09%	209M
BRAIN BIOTECH AG	-24.04%	65.34M
AFYREN	+7.81%	59.83M

Environmental Biotechnology